To include your compound in the COVID-19 Resource Center, submit it here.

MabThera regulatory update

FDA approved Rituxan rituximab in combination with glucocorticosteroids to treat Wegener's granulomatosis

Read the full 127 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE